Schott Pharma AG KGaAFRA:1SX -0.98%67 FCF Margin % is 26.24% as of Mar. 2026, which is 633% above its 10-year median of 3.58. GuruFocus rates FRA:1SX with a GF Score™ of 67/100 and a GF Value™ of €6.49. The stock has 2 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Schott Pharma AG KGaA ranks better than 64.46% on this metric.
The historical rank and industry rank for Schott Pharma AG KGaA's FCF Margin % or its related term are showing as below:
FRA:1SX'
s FCF Margin % Range Over the Past 10 Years
Min: 0.68 Med: 3.58 Max: 8.3
Current: 5.91
During the past 6 years, the highest FCF Margin % of Schott Pharma AG KGaA was 8.30%. The lowest was 0.68%. And the median was 3.58%.
FRA:1SX's FCF Margin % is ranked better than 64.46% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: -0.22
vs FRA:1SX: 5.91
Schott Pharma AG KGaA FCF Margin % Related Terms
Schott Pharma AG KGaA FCF Margin % Historical Data
* Premium members only.
The historical data trend for Schott Pharma AG KGaA's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:1SX vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Schott Pharma AG KGaA's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Schott Pharma AG KGaA FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Schott Pharma AG KGaA's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Schott Pharma AG KGaA's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Schott Pharma AG KGaA (FRA:1SX) has a FCF Margin % of 26.24% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Schott Pharma AG KGaA and its competitors. This is 633% above median its historical median of 3.58. Over the past decade, Schott Pharma AG KGaA's FCF Margin % has ranged from 0.68 to 8.30. According to the industry distribution chart, Schott Pharma AG KGaA ranks #290 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 35.5%.
Is Schott Pharma AG KGaA's FCF Margin % too high?
Schott Pharma AG KGaA's current FCF Margin % of 26.24% is 633% above median its 10-year median of 3.58. Over the past 10 years, this metric has ranged from a low of 0.68 to a high of 8.30. Based on the distribution chart, Schott Pharma AG KGaA ranks #290 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Schott Pharma AG KGaA has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Schott Pharma AG KGaA's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Schott Pharma AG KGaA ranks #290 out of 816 companies for FCF Margin %. This puts Schott Pharma AG KGaA in the upper half of its industry. Historically, Schott Pharma AG KGaA's own FCF Margin % has ranged from 0.68 to 8.30 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Schott Pharma AG KGaA and its competitors. Schott Pharma AG KGaA's current FCF Margin % is 26.24%, which is 633% above median its own 10-year median of 3.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Schott Pharma AG KGaA stock overvalued right now?
Schott Pharma AG KGaA (FRA:1SX) has a current FCF Margin % of 26.24%. The stock's GF Value™ is €6.49, compared to a current price of €4.04 — trading 37.8% below its estimated fair value. The current FCF Margin % is 26.24%, which is 633% above median its 10-year median of 3.58. Schott Pharma AG KGaA's overall GF Score™ is 67/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Schott Pharma AG KGaA (FRA:1SX), the current FCF Margin % is 26.24% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Schott Pharma AG KGaA (FRA:1SX) Overvalued in 2026?
Based on GuruFocus' analysis, Schott Pharma AG KGaA stock appears to be undervalued.
The current stock price of €4.04 is trading 37.8% below its estimated GF Value™ of €6.49.
Key valuation signals for FRA:1SX:
FCF Margin %: 26.24% (633% above median its 10-year median of 3.58)
GF Value™: €6.49 vs. price of €4.04 (37.8% below fair value)
No single metric tells the full story. See the FRA:1SX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Schott Pharma AG & CO KGaA is an international provider of drug containment solutions and delivery systems for injectable drugs for pharma, biotech and life-sciences. Its business operates in two segments: Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of revenue is being generated from the DCS segment, which includes products like vials, cartridges, and ampoules, and provides customers with sterile and non-sterile options in standard and high-end formats for drug storage. Geographically, the company generates revenue from Europe, the Middle East, Africa (EMEA), Asia and the South Pacific, North America, and South America.
67GF Score
Get the complete analysis for FRA:1SX
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1SX has been successfully added to your 
